Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2025 ▲▼ | Q2 2025 ▲▼ | Change ▲▼ | Q1 2025 ▲▼ | Q2 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Heron Therapeutics, Inc.(HRTX) | 6,986,744 | 6,986,744 | 0 | $15.37M | $14.46M | 14.47% | -$908.3K |
| VeronapharmaplcSPONSOREDADS | 95,000 | 95,000 | 0 | $6.03M | $8.99M | 8.99% | +$2.95M |
| Jasper Therapeutics, Inc.COMNEW(JSPR) | 1,433,828 | 1,433,828 | 0 | $6.17M | $7.96M | 7.96% | +$1.79M |
| Protara Therapeutics, Inc.COMSTK(TARA) | 1,667,800 | 2,139,000 | +471,200 | $7.10M | $6.48M | 6.48% | -$623.7K |
| Zevra Therapeutics, Inc.COMNEW(ZVRA) | 665,000 | 715,000 | +50,000 | $4.98M | $6.30M | 6.30% | +$1.32M |
| Tourmalinebioinc | 455,412 | 393,889 | -61,523 | $6.93M | $6.30M | 6.30% | -$628.5K |
| Praxis Precision Medicines, Inc.COMNEW(PRAX) | 185,000 | 149,334 | -35,666 | $7.01M | $6.28M | 6.28% | -$726.5K |
| CidaratherapeuticsincCOMNEW | 0 | 100,000 | +100,000 | $0 | $4.87M | 4.87% | +$4.87M |
| Alumisinc | 0 | 1,620,846 | +1,620,846 | $0 | $4.86M | 4.87% | +$4.86M |
| Arvinas, Inc.(ARVN) | 0 | 500,000 | +500,000 | $0 | $3.68M | 3.68% | +$3.68M |
| Scpharmaceuticalsinc | 917,668 | 917,668 | 0 | $2.41M | $3.50M | 3.50% | +$1.08M |
| Rezolute, Inc.COMNEW(RZLT) | 400,000 | 750,000 | +350,000 | $1.16M | $3.35M | 3.35% | +$2.19M |
| Liquidia CorporationCOMNEW(LQDA) | 300,000 | 239,260 | -60,740 | $4.42M | $2.98M | 2.98% | -$1.44M |
| Mineralys Therapeutics, Inc.(MLYS) | 150,600 | 174,600 | +24,000 | $2.39M | $2.36M | 2.36% | -$29.2K |
| Sutro Biopharma, Inc.(STRO) | 1,030,000 | 3,060,000 | +2,030,000 | $670.1K | $2.18M | 2.19% | +$1.51M |
| InspireMD, Inc.(NSPR) | 904,029 | 904,029 | 0 | $2.43M | $2.05M | 2.05% | -$379.7K |
| Perspective Therapeutics, Inc.COMNEW(CATX) | 500,000 | 500,000 | 0 | $1.06M | $1.72M | 1.72% | +$655.0K |
| Replimune Group, Inc.(REPL) | 182,083 | 183,083 | +1,000 | $1.78M | $1.70M | 1.70% | -$74.5K |
| TELA Bio, Inc.(TELA) | 747,410 | 747,410 | 0 | $911.8K | $1.45M | 1.45% | +$538.1K |
| Edesa Biotech, Inc.COMNEW(EDSA) | 687,500 | 687,500 | 0 | $1.68M | $1.40M | 1.40% | -$281.9K |
| Viridian Therapeutics, Inc.(VRDN) | 0 | 86,500 | +86,500 | $0 | $1.21M | 1.21% | +$1.21M |
| Upstream Bio, Inc.(UPB) | 107,000 | 107,000 | 0 | $654.8K | $1.17M | 1.18% | +$520.0K |
| Eledon Pharmaceuticals, Inc.(ELDN) | 323,973 | 338,973 | +15,000 | $1.10M | $918.6K | 0.92% | -$179.7K |
| Avalo Therapeutics, Inc.COMNEW(AVTX) | 111,972 | 154,972 | +43,000 | $896.9K | $773.3K | 0.77% | -$123.6K |
| Tenax Therapeutics, Inc.COMNEW(TENX) | 83,333 | 83,333 | 0 | $545.8K | $480.0K | 0.48% | -$65.8K |
| Corbus Pharmaceuticals Holdings, Inc.COMNEW(CRBP) | 59,000 | 59,000 | 0 | $313.3K | $407.1K | 0.41% | +$93.8K |
| Kiora Pharmaceuticals, Inc.(KPRX) | 122,223 | 122,223 | 0 | $367.9K | $352.0K | 0.35% | -$15.9K |
| Protagonisttherapeuticsinc | 0 | 3,700 | +3,700 | $0 | $204.5K | 0.20% | +$204.5K |
| CytomX Therapeutics, Inc.(CTMX) | 75,000 | 75,000 | 0 | $47.7K | $170.3K | 0.17% | +$122.6K |
| Nurix Therapeutics, Inc.(NRIX) | 0 | 10,000 | +10,000 | $0 | $113.9K | 0.11% | +$113.9K |
| Geron Corporation(GERN) | 655,000 | 70,000 | -585,000 | $1.04M | $98.7K | 0.10% | -$942.8K |
| Wave Life Sciences, Inc.SHS(WVE) | 13,000 | 15,000 | +2,000 | $105.0K | $97.5K | 0.10% | -$7.5K |
| Larimar Therapeutics, Inc.(LRMR) | 28,000 | 33,000 | +5,000 | $60.2K | $95.4K | 0.10% | +$35.2K |
| Gossamer Bio, Inc.(GOSS) | 75,000 | 75,000 | 0 | $82.5K | $92.3K | 0.09% | +$9.8K |
| ProqrthrapeuticsnvSHSEURO SHS EURO | 45,000 | 45,000 | 0 | $59.9K | $91.8K | 0.09% | +$31.9K |
| Ventyxbiosciencesinc | 40,000 | 40,000 | 0 | $46.0K | $85.6K | 0.09% | +$39.6K |
| Erasca, Inc.(ERAS) | 50,000 | 65,000 | +15,000 | $68.5K | $82.5K | 0.08% | +$14.1K |
| Alectorinc | 55,000 | 55,000 | 0 | $67.7K | $77.0K | 0.08% | +$9.3K |
| Ternspharmaceuticalsinc | 17,000 | 20,000 | +3,000 | $46.9K | $74.6K | 0.07% | +$27.7K |
| Design Therapeutics, Inc.(DSGN) | 14,000 | 20,000 | +6,000 | $54.0K | $67.4K | 0.07% | +$13.4K |
| Context Therapeutics Inc.(CNTX) | 90,000 | 100,000 | +10,000 | $55.1K | $65.5K | 0.07% | +$10.4K |
| Ovid Therapeutics Inc.(OVID) | 97,000 | 160,000 | +63,000 | $30.3K | $52.8K | 0.05% | +$22.5K |
| Immix Biopharma, Inc.(IMMX) | 0 | 25,000 | +25,000 | $0 | $51.8K | 0.05% | +$51.8K |
| Yarrow Bioscience Inc(YARW) | 0 | 30,000 | +30,000 | $0 | $49.5K | 0.05% | +$49.5K |
| Aclaris Therapeutics, Inc.(ACRS) | 35,000 | 32,700 | -2,300 | $53.5K | $46.4K | 0.05% | -$7.1K |
| 4dmoleculartherapeuticsin | 12,000 | 12,000 | 0 | $38.8K | $44.5K | 0.04% | +$5.8K |
| Pyxis Oncology, Inc.COMMONSTOCK(PYXS) | 0 | 40,000 | +40,000 | $0 | $44.0K | 0.04% | +$44.0K |
| PMV Pharmaceuticals, Inc.(PMVP) | 35,000 | 35,000 | 0 | $38.1K | $37.1K | 0.04% | -$1.1K |
| Nextcureinc | 25,000 | 45,000 | +20,000 | $12.0K | $20.7K | 0.02% | +$8.7K |
| Acelyrin Inc | 3,366,945 | 0 | -3,366,945 | $8.32M | $0 | — | -$8.32M |
| Elevation Oncology Inc | 45,000 | 0 | -45,000 | $11.7K | $0 | — | -$11.7K |
| Immunome, Inc.(IMNM) | 153,500 | 0 | -153,500 | $1.03M | $0 | — | -$1.03M |
| Instil Bio, Inc.(TIL) | 69,000 | 0 | -69,000 | $1.20M | $0 | — | -$1.20M |
| Kronos Bio Inc | 35,000 | 0 | -35,000 | $28.9K | $0 | — | -$28.9K |
| Regulus Therapeutics Inc | 80,000 | 0 | -80,000 | $140.0K | $0 | — | -$140.0K |
| Springworks Therapeutics Inc | 185,520 | 0 | -185,520 | $8.19M | $0 | — | -$8.19M |